On 2/12/25, Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) stock enjoyed a major increase of 13.0%, closing at $5.20. However, exceptionally low trading volume at 6% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 38.3% during the last week.
Current PriceTarget Research Rating
Cumberland Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Cumberland Pharmaceuticals has a very low Appreciation Score of 12 but a good Power Rating of 82, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment